tiprankstipranks
Tecnicas Reunidas, SA (GB:0MKT)
LSE:0MKT
Holding GB:0MKT?
Track your performance easily

Tecnicas Reunidas (0MKT) Income Statement

1 Followers

Tecnicas Reunidas Income Statement

Last quarter (Q4 2022), Tecnicas Reunidas's total revenue was €1.42B, an increase of 106.57% from the same quarter last year. In Q4, Tecnicas Reunidas's net income was €11.47M. See Tecnicas Reunidas’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 4.23B€ 4.23B€ 2.81B€ 3.52B€ 4.70B€ 4.40B
Cost of Revenue
€ 3.35B€ 3.35B€ 2.12B€ 2.56B€ 3.68B€ 3.44B
Gross Profit
€ 880.71M€ 880.71M€ 684.04M€ 957.43M€ 1.02B€ 959.68M
Operating Expense
€ 877.69M€ 877.69M€ 794.71M€ 873.52M€ 907.65M€ 878.07M
Operating Income
€ 3.02M€ 3.02M€ -110.66M€ 83.91M€ 111.95M€ 81.61M
Net Non Operating Interest Income Expense
€ -23.34M€ -23.34M€ -75.49M€ -66.78M€ -62.40M€ -43.55M
Other Income Expense
------
Pretax Income
€ -18.53M€ -18.53M€ -179.80M€ 19.88M€ 55.80M€ 22.29M
Tax Provision
€ 15.95M€ 15.95M€ 12.33M€ 6.90M€ 65.80M€ 7.84M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ -37.13M€ -37.13M€ -190.44M€ 11.05M€ -9.23M€ 11.97M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 36.43M€ 38.27M€ 42.11M€ 41.58M€ 64.52M
Total Expenses
€ 4.23B€ 4.23B€ 2.92B€ 3.44B€ 4.59B€ 4.31B
Net Income From Continuing And Discontinued Operation
€ -37.13M€ -37.13M€ -190.44M€ 11.05M€ -9.23M€ 11.97M
Normalized Income
€ -37.13M€ -36.91M€ -199.86M€ 4.52M€ -22.77M€ 13.62M
Interest Expense
€ 25.22M€ 25.22M€ 16.51M€ 15.53M€ 11.37M€ 9.39M
EBIT
€ 6.69M€ 6.69M€ -163.29M€ 35.41M€ 67.17M€ 31.68M
EBITDA
€ 32.55M€ 32.55M€ -135.88M€ 78.63M€ 109.26M€ 50.63M
Currency in EUR

Tecnicas Reunidas Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis